Skip to content

PRevalence Of Transient Global Amnesia in Obstructive Sleep Apnea Syndrome

PRevalence Of Transient Global Amnesia in Obstructive Sleep Apnea Syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06903026
Acronym
PROTOS
Enrollment
250
Registered
2025-03-30
Start date
2023-03-17
Completion date
2025-12-31
Last updated
2025-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transient Global Amnesia

Keywords

Transient Global Amnesia, Sleep apnea syndrome

Brief summary

Amnesic stroke is an amnestic syndrome lasting less than 24 hours characterized by the occurrence of anterograde amnesia often associated with retrograde amnesia, the pathophysiology of which is still poorly understood at present. A recent study on a small sample size (N=29) highlighted an association between obstructive sleep apnea syndrome and amnesic stroke. Our study seeks to confirm or refute these results on a larger cohort (N=200-250). A better understanding of the pathophysiological processes involved would open up new therapeutic avenues.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients seen for consultation in the Neuropsychology Department of Strasbourg University Hospital between March 1, 2015 and December 31, 2021 following an episode of amnestic stroke meeting the Hodges and Warlow criteria: * The stroke must have been documented and reported by a competent witness present during the stroke. * Anterograde amnesia during the stroke. * Absence of vigilance, personality, and cognitive disorders other than memory disorders (aphasia, apraxia, etc.). * Absence of focal neurological symptoms during the episode and its aftermath. * Absence of epileptic manifestations. * Resolution of the episode in less than 24 hours. * Exclusion of patients with a history of recent head trauma or active epilepsy (undergoing regular treatment or having experienced a seizure in the last 2 years). * Subjects who have not expressed opposition to the reuse of their data for scientific research purposes.

Exclusion criteria

* Patients who have expressed opposition to the retrospective reuse of their data for scientific research purposes. * Patients with active epilepsy * Patients with recent head trauma * Patients with an MMS \< or equal to 25 * Subject under guardianship or curatorship * Subject under judicial protection

Design outcomes

Primary

MeasureTime frameDescription
To assess the prevalence of obstructive sleep apnea syndrome in patients who have experienced an amnestic stroke.Within the last 2 yearsPresence or absence of obstructive sleep apnea syndrome reported by a witness present during the stroke.

Countries

France

Contacts

Primary ContactBenjamin CRETIN, MD
benjamin.cretin@chru-trasbourg.fr33 3 88 12 86 34

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026